2024-519646-73-00已完成1 期
A Phase I Randomized, Single-center, Double-blind, Two-period Crossover Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Icodec in Participants with Type 2 Diabetes.
Gan & Lee Pharmaceuticals USA Corp.1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2025年3月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Olena Kucheruk
Scientific
Gan & Lee Pharmaceuticals USA Corp.
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Phase 1 Clinical study, Safety, Tolerability and PK of SP-8203Diseases of the nervous systemKCT0001742Shin Poong Pharm72
已完成
不适用
A Phase I, single*center, double-blind, randomized, placebo-controlled, single and multiple ascending dose trial to evaluate the safety and pharmacokinetics of PTC857 in healthy volunteers.10007951Parkinson's DiseaseNL-OMON49571PTC Therapeutics, Inc.82
尚未招募
不适用
A single-center, double-blind, randomized, phase I/II dose escalating study to assess the safety, tolerability and immunogenicity of three doses of the therapeutic synthetic long peptide (SLP) vaccine (ISA104) in patients with chronic hepatitis B (cHBV).chronic hepatitis BcHBV10047438NL-OMON51362Erasmus MC, Universitair Medisch Centrum Rotterdam24
尚未招募
1 期
A Phase 1, Single Centre, Randomized, Double Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NeuroDirect Ketamine in Healthy Adult VolunteersMental Health - Other mental health disordersPost-traumatic stress disorderACTRN12623000061639Psycheceutical, Inc24
已完成
1 期
A Phase I, Single Centre, Double Blind, Randomised, Placebo Controlled, Single Escalating Dose Study to Determine the Safety, Tolerability and Absorption of Ha44 Administered Topically to the Hair and Scalp of Healthy VolunteersHealthy subjectsOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12607000014459Hatchtech Pty Ltd32